S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Will Nvidia Be the Lifeline Intel Desperately Needs?
The Graphite Shortage Story You're Not Being Told (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
The Graphite Shortage Story You're Not Being Told (Ad)
Analysts are Giving ChargePoint a Boost, but is it a Buy?
VirTra is an Overlooked Profitable National Defense Play
The Graphite Shortage Story You're Not Being Told (Ad)
US Navy says Iran Revolutionary Guard fast-attack boats 'harassed' ship in Strait of Hormuz
Greek authorities rescue 91 migrants from river islet on border with Turkey
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Will Nvidia Be the Lifeline Intel Desperately Needs?
The Graphite Shortage Story You're Not Being Told (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
The Graphite Shortage Story You're Not Being Told (Ad)
Analysts are Giving ChargePoint a Boost, but is it a Buy?
VirTra is an Overlooked Profitable National Defense Play
The Graphite Shortage Story You're Not Being Told (Ad)
US Navy says Iran Revolutionary Guard fast-attack boats 'harassed' ship in Strait of Hormuz
Greek authorities rescue 91 migrants from river islet on border with Turkey
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Will Nvidia Be the Lifeline Intel Desperately Needs?
The Graphite Shortage Story You're Not Being Told (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
The Graphite Shortage Story You're Not Being Told (Ad)
Analysts are Giving ChargePoint a Boost, but is it a Buy?
VirTra is an Overlooked Profitable National Defense Play
The Graphite Shortage Story You're Not Being Told (Ad)
US Navy says Iran Revolutionary Guard fast-attack boats 'harassed' ship in Strait of Hormuz
Greek authorities rescue 91 migrants from river islet on border with Turkey
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Will Nvidia Be the Lifeline Intel Desperately Needs?
The Graphite Shortage Story You're Not Being Told (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
The Graphite Shortage Story You're Not Being Told (Ad)
Analysts are Giving ChargePoint a Boost, but is it a Buy?
VirTra is an Overlooked Profitable National Defense Play
The Graphite Shortage Story You're Not Being Told (Ad)
US Navy says Iran Revolutionary Guard fast-attack boats 'harassed' ship in Strait of Hormuz
Greek authorities rescue 91 migrants from river islet on border with Turkey
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Forecast, Price & News

$0.29
+0.02 (+5.45%)
(As of 06/2/2023 08:47 PM ET)
Compare
Today's Range
$0.28
$0.31
50-Day Range
N/A
52-Week Range
$0.18
$3.94
Volume
124,800 shs
Average Volume
285,604 shs
Market Capitalization
$4.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

See More Headlines

AMPE Price History

AMPE Company Calendar

Last Earnings
5/08/2023
Today
6/05/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-16,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.78 per share

Miscellaneous

Free Float
14,970,000
Market Cap
$4.38 million
Optionable
Optionable
Beta
1.82

Key Executives

  • Michael A. Martino
    Chief Executive Officer & Director
  • Daniel G. Stokely
    Chief Financial Officer & Secretary
  • Howard Levy
    Chief Medical Officer
  • Lane Hapke
    Vice President-Manufacturing Operations
  • Laura Goldberg
    Vice President-Quality & Regulatory Operations













AMPE Stock - Frequently Asked Questions

How have AMPE shares performed in 2023?

Ampio Pharmaceuticals' stock was trading at $0.2750 at the beginning of the year. Since then, AMPE stock has increased by 5.5% and is now trading at $0.29.
View the best growth stocks for 2023 here
.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) posted its earnings results on Monday, May, 8th. The company reported ($0.26) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMPE."

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.29.

How much money does Ampio Pharmaceuticals make?

Ampio Pharmaceuticals (NYSE:AMPE) has a market capitalization of $4.38 million.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 INVERNESS PARKWAY SUITE 200, ENGLEWOOD CO, 80112. The official website for the company is www.ampiopharma.com. The company can be reached via phone at (720) 437-6500, via email at info@ampiopharma.com, or via fax at 720-437-6501.

This page (NYSE:AMPE) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -